From Polymorphisms to Phenotypes: SMAD3 rs17293632 and LTBP3 rs11545200 in Pediatric Inflammatory Bowel Disease
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Genetic variants in SMAD3 and LTBP3 influence pediatric inflammatory bowel disease (IBD) severity. These findings may help tailor treatments for children with Crohn's disease (CD) and ulcerative colitis (UC).
Area Of Science
- Genetics and Genomics
- Pediatric Gastroenterology
- Immunology
Background
- Early-onset inflammatory bowel disease (IBD), encompassing Crohn's disease (CD) and ulcerative colitis (UC), often exhibits a more severe clinical trajectory.
- Genetic factors, particularly within the transforming growth factor-beta (TGF-β) signaling pathway, are critical in IBD pathogenesis.
- SMAD3 and LTBP3 genes, integral to TGF-β signaling, have been previously linked to IBD through genome-wide association studies.
Purpose Of The Study
- To investigate the clinical relevance of specific polymorphisms in SMAD3 (rs17293632) and LTBP3 (rs11545200) within a pediatric IBD cohort.
- To correlate these genetic variants with clinical disease characteristics, including age at diagnosis, inflammatory markers, growth parameters, and treatment responses.
Main Methods
- A cohort of 286 pediatric patients (133 with UC, 153 with CD) was recruited from seven Polish pediatric centers.
- Genotyping was performed for the SMAD3 rs17293632 and LTBP3 rs11545200 polymorphisms.
- Clinical data collected included age at diagnosis, C-reactive protein (CRP) levels, albumin levels, weight, height, BMI Z-scores, and therapeutic interventions.
Main Results
- The minor allele of LTBP3 rs11545200 was significantly associated with earlier diagnosis, poorer nutritional status during flares, and increased infliximab use, especially in UC patients.
- In CD patients, the SMAD3 rs17293632 major homozygous genotype correlated with higher systemic corticosteroid usage, indicating a potentially more severe or refractory disease phenotype.
- These genetic variations within the TGF-β pathway are linked to distinct clinical presentations in pediatric IBD.
Conclusions
- Polymorphisms in LTBP3 and SMAD3 are associated with specific clinical features in pediatric IBD patients.
- These genetic markers may serve as predictive biomarkers for disease severity and guide personalized treatment strategies in children with IBD.
- Further research into TGF-β pathway genetics can enhance tailored therapeutic approaches for pediatric IBD.
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
Related Concept Videos
Pleiotropy is the phenomenon in which a single gene impacts multiple, seemingly unrelated phenotypic traits. For example, defects in the SOX10 gene cause Waardenburg Syndrome Type 4, or WS4, which can cause defects in pigmentation, hearing impairments, and an absence of intestinal contractions necessary for elimination. This diversity of phenotypes results from the expression pattern of SOX10 in early embryonic and fetal development. SOX10 is found in neural crest cells that form melanocytes,...
Overview
A pedigree is a diagram displaying a family’s history of a trait. Analyzing pedigrees can reveal (1) whether a trait is dominant or recessive, (2) the type of chromosome, autosomal or sex, a trait is linked to, (3) genotypes of family members, and (4) probabilities of phenotypes in future generations. For families with a history of autosomal or sex-linked diseases, this information can be crucial to family planning.
Pedigrees Display Family Histories
In various plant and...
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...